Skip to main content

Peer Review reports

From: A phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinoma

Original Submission
18 Nov 2015 Submitted Original manuscript
23 Feb 2016 Reviewed Reviewer Report - Zhao-Chong Zeng
29 Feb 2016 Reviewed Reviewer Report - Hirotsugu Kenmotsu
30 Mar 2016 Author responded Author comments - Yiyu Lu
Resubmission - Version 2
30 Mar 2016 Submitted Manuscript version 2
25 Apr 2016 Reviewed Reviewer Report - Hirotsugu Kenmotsu
11 May 2016 Author responded Author comments - Yiyu Lu
Resubmission - Version 3
11 May 2016 Submitted Manuscript version 3
16 May 2016 Reviewed Reviewer Report - Hirotsugu Kenmotsu
16 May 2016 Reviewed Reviewer Report - Hirotsugu Kenmotsu
18 May 2016 Author responded Author comments - Yiyu Lu
Resubmission - Version 4
18 May 2016 Submitted Manuscript version 4
7 Jul 2016 Author responded Author comments - Yiyu Lu
Resubmission - Version 5
7 Jul 2016 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
1 Sep 2016 Author responded Author comments - Yiyu Lu
Resubmission - Version 7
1 Sep 2016 Submitted Manuscript version 7
Publishing
22 Sep 2016 Editorially accepted
7 Oct 2016 Article published 10.1186/s12885-016-2800-5

You can find further information about peer review here.

Back to article page